After reconstitution, store between 2 and 8C and use within 7 to 14 days
Many plans require prior authorization, a BMI threshold, and documentation of previous failed weight loss attempts, and coverage is often denied for weight loss indications entirely
Further controlled human studies are necessary to clarify safety parameters, long term outcomes, and any potential translational relevance within clinical research frameworks
GLP-1 receptor agonists increase the risk of cholelithiasis (gallstones)
More serious side effects of tesamorelin include: Swelling Increased blood sugar and/or diabetes Increased risk of cancer or reactivation of cancer Elevated levels of insulin-like growth factor Allergic reaction 6 Recommended Dosage and Time for Injection Egrifta is provided as vials, which contain two milligrams (mg) total of drug
Do I have to come off at all